|
|
||||||||
Letters |
1
Dept. of Res. and Dev., Hybritech Incorporated, subsidiary of Beckman Instruments, Inc., San Diego, CA 92196,
2
The Miami Project to Cure Paralysis, and the Dept. of Urol., Univ. of Miami School of Med., Miami, FL 33136
a Author for correspondence. Hybritech Incorporated, P.O. Box 269009, San Diego, CA 92196-9006. Fax 619-621-4610.
To the Editor:
Prostate specific antigen (PSA) is an important tumor marker for
the detection and monitoring of prostate cancer. PSA is secreted by the
prostatic epithelial cells into the lumen of the prostate duct during
the formation of seminal plasma. PSA is a 30 kDa serine protease that
cleaves biological substrates in seminal fluid, including seminogelin
I, seminogelin II, and fibronectin, into small peptides, resulting in
increased sperm motility (1)(2)(3)(4). PSA has also been shown to
cleave other biological substrates, including insulin-like growth
factor-binding protein-3 and laminin,
References
The following articles in journals at HighWire Press have cited this article:
![]() |
Y. Fujii, S. Kawakami, Y. Okada, Y. Kageyama, and K. Kihara Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E927 - E931. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |